CAMP4 THERAPEUTICS CORPORATION (CAMP)
Healthcare
Biotechnology
3.50 $
-0.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns CAMP4 THERAPEUTICS CORPORATION (CAMP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.0% of the shares are freely tradable; institutional investors hold 86.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
86.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
13.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
51.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
52Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 12.15 | 6,307,636 | +0.0 | 03/31/2026 |
| 5AM Venture Management, LLC | 11.30 | 5,869,091 | +0.0 | 03/31/2026 |
| FMR Inc | 9.50 | 4,933,432 | +0.3 | 03/31/2026 |
| Vivo Capital, LLC | 8.18 | 4,246,568 | +0.0 | 03/31/2026 |
| Balyasny Asset Management LLC | 5.07 | 2,632,437 | +8.0 | 03/31/2026 |
| Enavate Sciences GP, LLC | 4.22 | 2,190,920 | -27.8 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 3.78 | 1,960,784 | -10.1 | 03/31/2026 |
| Trails Edge Capital Partners, LP | 3.74 | 1,939,563 | -2.2 | 03/31/2026 |
| Vanguard Group Inc | 3.22 | 1,672,960 | +433.6 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.96 | 1,534,768 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.